Literature DB >> 23105599

Place of salivary β glucuronidase activity in head & neck cancers.

M S Ghadge1, A S Raste.   

Abstract

Salivary β-glucuronidase activity was studied in 20 healthy subjects without habits and 10 with habits, 38 untreated patients of advanced head and neck cancer and 21 patients after treatment either after surgery or radiation.Salivary β-glucuronidase activity was elevated in untreated cases of head and neck cancer (p<0.001), with a fall in the activity after treatment. The post operative fall in the activity of salivary β-glucuronidase activity was highly significant (p<0.001) as compared to post radiation. This test can be utilized in the diagnosis and also for monitoring the course of the disease.

Entities:  

Year:  2006        PMID: 23105599      PMCID: PMC3453754          DOI: 10.1007/BF02913096

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  5 in total

1.  Application of an improved glucuronidase assay method to the study of human blood beta-glucuronidase.

Authors:  W H FISHMAN; B SPRINGER; R BRUNETTEI
Journal:  J Biol Chem       Date:  1948-04       Impact factor: 5.157

2.  Comparison between p-nitrophenyl glucuronide and phenolphthalein glucuronide as substrates in the assay of beta-glucuronidase.

Authors:  G Szasz
Journal:  Clin Chem       Date:  1967-09       Impact factor: 8.327

3.  Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Comparison with conventional urine cytologic evaluation.

Authors:  K J Ho; S H Kuo
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

4.  Modified method for determination of serum beta-glucuronidase: A comparative study using P-nitrophenyl glucuronide and phenolphthalein glucuronide as substrate in gastrointestinal tract carcinomas.

Authors:  M M Khanolkar; A V Sirsat; S S Walvekar; M S Bhansali; L J Desouza
Journal:  Indian J Clin Biochem       Date:  1997-12

5.  Urinary beta-glucuronidase in screening and followup of primary urinary tract malignancy.

Authors:  K J Ho
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.